Migliaccio & Rathod LLP is currently investigating several skincare and cosmetics brands, including Clinique and Clearasil, due to reports of high levels of benzene in their acne treatment products. Benzene, a known carcinogen, is high on the FDA’s list of dangerous solvents, and long-term exposure can lead to serious health issues. In the shorter term, someone exposed to a high concentration of benzene may experience dizziness, headaches, and irregular heartbeat. Over time, inhaling or absorbing large quantities of benzene can lead to anemia, blood cancers, and immunodeficiencies.
Independent testing from Connecticut-based lab Valisure found that certain acne treatment products contained upwards of 800 times the federal limit of benzene. Valisure has since filed a petition with the FDA requesting a formal investigation and several product recalls. The benzene levels recently identified in acne treatment products are significantly higher than other skincare and cosmetic products, as acne products often contain benzoyl peroxide. Additionally, the air around the acne products was found to contain high levels of benzene, suggesting that the chemical could leak out of the packaging and lead to benzene inhalation.
Have you purchased or used an acne treatment product containing benzoyl peroxide?
If so, we would like to hear from you. Please complete the questionnaire on this page, send an email to [email protected], or give us a call at (202) 470-3520.
Committed to Consumer Protection
The lawyers at Migliaccio & Rathod LLP have years of experience in class action litigation against large corporations, including in cases involving unfair and deceptive trade practices. More information about our current cases and investigations is available on our blog.